RNA interference of interferon regulatory factor-1 gene expression in THP-1 cell line leads to Toll-like receptor-4 overexpression/activation as well as up-modulation of annexin-II.

Interferon regulatory factor-1 (IRF-1) is a candidate transcription factor for the regulation of the Toll-like receptor-4 (TLR-4) gene. Using a small interfering RNA-based (siRNA) process to silence IRF-1 gene expression in the leukemic monocytic cell line THP-1, we investigated whether such a modulation would alter TLR-4 expression and activation status in these cells. The siIRF-1 cells expressed elevated levels of TLR-4 mRNA and protein compared to controls by 90% and 77%, respectively. ICAM.1 protein expression and apoptosis levels were increased by 8.35- and 4.25-fold, respectively. The siIRF-1 cells overexpressed Bax mRNA compared to controls. Proteomic analysis revealed upmodulation of the Annexin-II protein in siIRF-1 THP-1 cells. Myelodysplastic syndrome (MDS) patients with an absence of full-length IRF-1 mRNA also overexpressed Annexin-II. It is plausible that this overexpression may lead to the activation of TLR-4 contributing to the increased apoptosis characterizing MDS.

[1]  E. Andreakos,et al.  Toll-like Receptor-4 Is Up-Regulated in Hematopoietic Progenitor Cells and Contributes to Increased Apoptosis in Myelodysplastic Syndromes , 2007, Clinical Cancer Research.

[2]  K. Ozato,et al.  Identification of IRF-8 and IRF-1 target genes in activated macrophages. , 2007, Molecular immunology.

[3]  B. Hoffman,et al.  Interferon regulatory factor-1 myelodysplasia and leukemia. , 2006, Leukemia research.

[4]  K. Honda,et al.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors , 2006, Nature Reviews Immunology.

[5]  S. Giannouli,et al.  Aberrant alternative splicing of interferon regulatory factor-1 (IRF-1) in myelodysplastic hematopoietic progenitor cells. , 2006, Leukemia research.

[6]  David L. Williams,et al.  Overexpression of TLR2 and TLR4 susceptibility to serum deprivation-induced apoptosis in CHO cells. , 2005, Biochemical and biophysical research communications.

[7]  P. Moynagh.  TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. , 2005, Trends in immunology.

[8]  M. Feldmann,et al.  Is targeting Toll‐like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine‐driven inflammation? , 2004, Immunological reviews.

[9]  S. Olwill,et al.  Annexin A2 expression during cellular differentiation in myeloid cell lines. , 2004, Biochemical Society transactions.

[10]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[11]  Liwu Li,et al.  Characterization of Tollip protein upon Lipopolysaccharide challenge. , 2004, Molecular immunology.

[12]  S. Giannouli,et al.  Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression , 2004, Annals of the Rheumatic Diseases.

[13]  J. Heesemann,et al.  A Dominant Role of Toll-Like Receptor 4 in the Signaling of Apoptosis in Bacteria-Faced Macrophages 1 , 2003, The Journal of Immunology.

[14]  K. Kiyosawa,et al.  RNA interference is a functional pathway with therapeutic potential in human myeloid leukemia cell lines , 2003, Cancer Gene Therapy.

[15]  P. Sideras,et al.  Low expression of interferon regulatory factor‐1 and identification of novel exons skipping in patients with chronic myeloid leukaemia , 2002, British journal of haematology.

[16]  O. Donzé,et al.  RNA interference in mammalian cells using siRNAs synthesized with T7 RNA polymerase. , 2002, Nucleic acids research.

[17]  W. Buurman,et al.  In Vivo Expression of Toll-Like Receptor 2 and 4 by Renal Epithelial Cells: IFN-γ and TNF-α Mediated Up-Regulation During Inflammation1 , 2002, The Journal of Immunology.

[18]  H. Shin,et al.  Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. , 2002, The Journal of pharmacology and experimental therapeutics.

[19]  Hansjörg Hauser,et al.  Review: Activities of IRF-1 , 2002 .

[20]  Hansjörg Hauser,et al.  Activities of IRF-1. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[21]  W. Hancock,et al.  Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 41 , 2001, The Journal of Immunology.

[22]  Jerome F. Strauss,et al.  The Extra Domain A of Fibronectin Activates Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[23]  M. Fenton,et al.  Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[24]  A. Aderem,et al.  Toll-like receptors in the induction of the innate immune response , 2000, Nature.

[25]  P. Godowski,et al.  The apoptotic signaling pathway activated by Toll‐like receptor‐2 , 2000, The EMBO journal.

[26]  T. Taniguchi,et al.  The interferon regulatory factors and oncogenesis. , 2000, Seminars in cancer biology.

[27]  J. Tschopp,et al.  TRAIL receptor-2 signals apoptosis through FADD and caspase-8 , 2000, Nature Cell Biology.

[28]  L. Schwarzfischer,et al.  PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene* , 2000, The Journal of Biological Chemistry.

[29]  H. Kwon,et al.  Interferon regulatory factors: the next generation. , 1999, Gene.

[30]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.

[31]  V. Briner,et al.  Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. , 1999, Kidney international.

[32]  M. McLaughlin,et al.  Annexin II and bleeding in acute promyelocytic leukemia. , 1999, The New England journal of medicine.

[33]  E. Eklund,et al.  PU.1, Interferon Regulatory Factor 1, and Interferon Consensus Sequence-binding Protein Cooperate to Increase gp91 phox Expression* , 1998, The Journal of Biological Chemistry.

[34]  T. Taniguchi,et al.  IRF-1: the transcription factor linking the interferon response and oncogenesis. , 1997, Biochimica et biophysica acta.

[35]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[36]  A. Zeiher,et al.  Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax. , 1996, European journal of pharmacology.

[37]  T. Taniguchi,et al.  Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation. , 1994, Oncogene.

[38]  K. Hajjar,et al.  An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. , 1994, The Journal of biological chemistry.

[39]  al. et,et al.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia , 1993, Science.

[40]  D. Liebermann,et al.  Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[41]  T. Taniguchi,et al.  Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated , 1990, Cell.

[42]  Takashi Miyata,et al.  Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes , 1989, Cell.

[43]  T. Taniguchi,et al.  Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1 , 1989, Nature.

[44]  T. Taniguchi,et al.  Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. , 1989, Nature.

[45]  T. Taniguchi,et al.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements , 1988, Cell.